In addition, the deletion of the HLA-DRB1*11 allele is associated (beneficial effect) with obesity/overweight (OR = 0.13; 95% CI [0.01–1.14]; and p = 0.03) which is a risk for breast cancer. This evidence concerns the gene HLA-DRB1 and obesity due to melanocortin 4 receptor deficiency.